NCT04327791View on ClinicalTrials.gov

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

April 3, 2020

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2025

Conditions

Influenza

Interventions

DRUG

Baloxavir

administered PO once

DRUG

Placebos

administered PO once

Trial Locations (3)

13326

RECRUITING

Bassett Medical Center, Cooperstown

97239

RECRUITING

Oregon Health & Science University, Portland

01199

RECRUITING

Baystate Medical Center, Springfield

Sponsors

Lead Sponsor

Bassett Healthcare

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

collaborator

Viroclinics Biosciences B.V.

INDUSTRY

lead

Bassett Healthcare

OTHER